According to his brother Revanasiddappa, who works as a driver, Nagesh had no prior health issues before participating in the trial.

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Syngene International declined 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.